Articles

Obesity alone may be the best predictor of undiagnosed diabetes, according to the results of the Diabscreen Study recently reported in a published journal.

Patients with diabetes and coexisting depression face substantially elevated mortality risks beyond cardiovascular deaths, according to the results of a prospective cohort study recently published.

The results of a new clinical study demonstrate that the plaque and gingivitis germ-killing action of Listerine® Antiseptic significantly reduces the amount of germs that travel from the mouth to the bloodstream in people with mild to moderate gingivitis, which can affect diabetes and CVD. These findings are significant, as …

Months after withdrawal of the interleukin-1 receptor antagonist (IL-1Ra) anakinra, patients with Type 2 diabetes still show improvements in beta cell function, hemoglobin A1c levels, and markers of systemic inflammation, according to a new published report.

Weight loss may help preserve renal function in obese people with kidney disease, according to the results of a systematic review and meta-analysis just published.

In a new study it was shown that middle-aged women with large abdominal fat cells have a higher risk of developing Type 2 diabetes later in life compared to women with smaller fat cells.

Treating pregnant women for mild gestational diabetes resulted in fewer cesarean sections and other serious birthing problems associated with larger than average babies, according to a recent study.

The Faustman Lab at Massachusetts General Hospital, run by Denise L. Faustman, MD, PhD, is moving rapidly through the clinical trial challenge to test and possibly establish a vaccine using a generic drug, Bacillus Calmette-Guérin (BCG) to reverse Type 1 diabetes. 

The National Community Pharmacists Association (NCPA) and the American Association of Diabetes Educators (AADE) today announced a partnership that will expand counseling options for patients while offering community pharmacies a path to be compensated by Medicare and other insurers for diabetes management.

When metformin and a sulfonylurea or a glinide fail to bring Type 2 diabetes under control, adding pioglitazone may do the trick, French research suggests.